Organization | WCCT Global

WCCT Global Report issue

For profit Phase 1 Phase 2 Phase 4

Founded: Cypress CA United States (1998)

Status: Acquired by Altasciences Company Inc. (2021) → now Novo Nordisk (2021)

Organization Overview

First Clinical Trial

2005

NCT00311519

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Active Ingredients

Drugs in Phase 4 Trials (2)

colchicine (colbenemid) (1 trial)

hyaluronidase (human recombinant) (Hylenex) (1 trial)

Drugs in Phase 2 Trials (8)

Key: WCCT Global (6) Acquired (2)

becaplermin (regranex) (1 trial)

budesonide (rhinocort) (1 trial)

heat-labile enterotoxin of e. coli (1 trial)

insulin human (humulin) (1 trial)

insulin lispro (humalog) (1 trial)

ipl512,602 (1 trial)

olopatadine (patanol) (1 trial)

pacritinib (Vonjo) (1 trial)

Drugs in Phase 1 Trials (32)

Key: WCCT Global (30) Acquired (2)

aclerastide (1 trial)

albumin (Human) (Plasbumin) (1 trial)

albuterol (proventil) (1 trial)

bevacizumab (avastin) (1 trial)

calcifediol (1 trial)

cromoglicic acid (Intal) (1 trial)

diltiazem (cardizem) (1 trial)

dinalbuphine (1 trial)

fruquintinib (Inrebic) (2 trials)

furaprevir (2 trials)

inactivated influenza vaccine (1 trial)

itraconazole (sporanox) (2 trials)

methyldopa (aldomet) (1 trial)

midazolam (versed) (1 trial)

mod-4023 (1 trial)

mt1013 (1 trial)

nalbuphine (nubain) (1 trial)

ngp 555 (2 trials)

pul-042 (1 trial)

rabeprazole (pariet) (2 trials)

rifampin (2 trials)

rsifn-co (1 trial)

sotatercept (1 trial)

surufatinib (1 trial)

tld1433 (1 trial)

trastuzumab (herceptin) (1 trial)

ttp889 (1 trial)

vxa-a1.1 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acne Vulgaris (Phase 1)

Alzheimer Disease (Phase 1)

Ascites (Phase 1)

Asthma (Phase 2)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 1 (Phase 1)

Diarrhea (Phase 2)

Hemorrhagic Fevers, Viral (Phase 1)

Hepatitis (Phase 1)

Hepatitis C (Phase 1)

Hepatitis C, Chronic (Phase 1)

Hyperparathyroidism (Phase 1)

Hyperparathyroidism, Secondary (Phase 1)

Influenza, Human (Phase 1)

Malnutrition (Phase 1)

Marburg Virus Disease (Phase 1)

Osteoporosis (Phase 1)

Renal Insufficiency (Phase 4)

Respiratory Aspiration (Phase 1)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Urinary Bladder Neoplasms (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 36
# of Trial APIs: 42